Abstract
Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.
| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 735-752 |
| Number of pages | 18 |
| Journal | Pancreas |
| Volume | 39 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2010 |
Research programs
- EMC MM-01-39-01